Literature DB >> 7896671

Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome.

A J Allen1, H L Leonard, S E Swedo.   

Abstract

A review of clinical observations and literature reports leads to the hypothesis that, via a process analogous to Sydenham's chorea, infections with group A beta-hemolytic streptococci, among others, may trigger autoimmune responses that cause or exacerbate some cases of childhood-onset obsessive-compulsive disorder (OCD) or tic disorders (including Tourette's syndrome). If this hypothesis is correct, then immunological treatments should lead to decreased symptoms in some cases. Four cases with abrupt, severe onset or worsening of OCD or tics are presented from an open treatment study. All were boys aged 10 to 14 years. One had OCD, one had Tourette's syndrome, and two had both OCD and Tourette's syndrome. Clinically and on standardized rating scales, their symptoms were in the moderate to very severe range. Two had evidence of recent group A beta-hemolytic streptococci infections, and the others had histories of recent viral illnesses. Two were treated with plasmapheresis, one with intravenous immunoglobulin, and one with immunosuppressive doses of prednisone. All had a clinically significant response immediately after treatment. Diagnostic criteria are provided that describe these cases of pediatric, infection-triggered, autoimmune neuropsychiatric disorders (PITANDs). Suggestions are made regarding the evaluation and management of patients who may have this condition.

Entities:  

Mesh:

Year:  1995        PMID: 7896671     DOI: 10.1097/00004583-199503000-00015

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  40 in total

1.  Immediate and long term outcome after infrathalamic and thalamic lesioning for intractable Tourette's syndrome.

Authors:  T B Babel; P C Warnke; C B Ostertag
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

2.  Pediatric Acute-Onset Neuropsychiatric Syndrome Response to Oral Corticosteroid Bursts: An Observational Study of Patients in an Academic Community-Based PANS Clinic.

Authors:  Kayla Brown; Cristan Farmer; Bahare Farhadian; Joseph Hernandez; Margo Thienemann; Jennifer Frankovich
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-07-17       Impact factor: 2.576

Review 3.  Obsessive-Compulsive Disorder: Autoimmunity and Neuroinflammation.

Authors:  Mona Gerentes; Antoine Pelissolo; Krishnamoorthy Rajagopal; Ryad Tamouza; Nora Hamdani
Journal:  Curr Psychiatry Rep       Date:  2019-08-01       Impact factor: 5.285

4.  Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance.

Authors:  J T Walkup; M C LaBuda; H S Singer; J Brown; M A Riddle; O Hurko
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

5.  High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period.

Authors:  W Louis Cleveland; Robert L DeLaPaz; Rashid A Fawwaz; Roger S Challop
Journal:  Neural Plast       Date:  2010-02-18       Impact factor: 3.599

6.  PANDAS and comorbid Kleine-Levin syndrome.

Authors:  Diana M Gerardi; Joseph Casadonte; Priyal Patel; Tanya K Murphy
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-10-20       Impact factor: 2.576

7.  A pilot trial of cognitive-behavioral therapy augmentation of antibiotic treatment in youth with pediatric acute-onset neuropsychiatric syndrome-related obsessive-compulsive disorder.

Authors:  Joshua M Nadeau; Cary Jordan; Robert R Selles; Monica S Wu; Morgan A King; Priyal D Patel; Camille E Hanks; Elysse B Arnold; Adam B Lewin; Tanya K Murphy; Eric A Storch
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-05       Impact factor: 2.576

Review 8.  Predicting the outcome of treatment.

Authors:  J S March; J F Curry
Journal:  J Abnorm Child Psychol       Date:  1998-02

9.  Identification of pyruvate kinase as an antigen associated with Tourette syndrome.

Authors:  Janice W Kansy; Liliya Katsovich; Kevin S McIver; Jennifer Pick; John B Zabriskie; Paul J Lombroso; James F Leckman; James A Bibb
Journal:  J Neuroimmunol       Date:  2006-10-02       Impact factor: 3.478

Review 10.  Immune-mediated animal models of Tourette syndrome.

Authors:  Mady Hornig; W Ian Lipkin
Journal:  Neurosci Biobehav Rev       Date:  2013-01-10       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.